IRIS
DENTONE, CHIARA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 9.572
NA - Nord America 1.557
AS - Asia 1.475
Continente sconosciuto - Info sul continente non disponibili 231
SA - Sud America 151
AF - Africa 31
OC - Oceania 2
Totale 13.019
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 9.325
US - Stati Uniti d'America 1.449
SG - Singapore 559
CN - Cina 320
VN - Vietnam 271
BD - Bangladesh 165
BR - Brasile 90
FR - Francia 74
CA - Canada 45
FI - Finlandia 45
HK - Hong Kong 43
DE - Germania 31
GB - Regno Unito 22
AR - Argentina 21
MX - Messico 21
NL - Olanda 16
JP - Giappone 15
IN - India 13
CO - Colombia 12
IQ - Iraq 12
ID - Indonesia 11
PK - Pakistan 11
ZA - Sudafrica 10
EC - Ecuador 9
JM - Giamaica 9
PH - Filippine 8
CR - Costa Rica 7
ES - Italia 7
TH - Thailandia 7
UA - Ucraina 7
VE - Venezuela 7
CH - Svizzera 6
HN - Honduras 6
RU - Federazione Russa 6
TR - Turchia 6
AE - Emirati Arabi Uniti 5
CL - Cile 5
PT - Portogallo 5
DZ - Algeria 4
MY - Malesia 4
NP - Nepal 4
PY - Paraguay 4
SA - Arabia Saudita 4
SE - Svezia 4
DO - Repubblica Dominicana 3
EG - Egitto 3
ET - Etiopia 3
GR - Grecia 3
GT - Guatemala 3
IE - Irlanda 3
KE - Kenya 3
KR - Corea 3
SV - El Salvador 3
TN - Tunisia 3
AG - Antigua e Barbuda 2
AT - Austria 2
AU - Australia 2
AZ - Azerbaigian 2
BE - Belgio 2
HR - Croazia 2
HU - Ungheria 2
IR - Iran 2
JO - Giordania 2
RS - Serbia 2
TT - Trinidad e Tobago 2
TW - Taiwan 2
UY - Uruguay 2
UZ - Uzbekistan 2
BB - Barbados 1
BZ - Belize 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
GA - Gabon 1
GE - Georgia 1
KG - Kirghizistan 1
KY - Cayman, isole 1
LC - Santa Lucia 1
LT - Lituania 1
MA - Marocco 1
MD - Moldavia 1
MK - Macedonia 1
MQ - Martinica 1
MT - Malta 1
NG - Nigeria 1
PA - Panama 1
PE - Perù 1
PL - Polonia 1
PR - Porto Rico 1
PS - Palestinian Territory 1
SC - Seychelles 1
SI - Slovenia 1
SN - Senegal 1
SY - Repubblica araba siriana 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 12.789
Salva come PNG Salva come JPEG
Città #
Genoa 4.009
Genova 3.095
Rapallo 1.049
Vado Ligure 878
San Jose 372
Singapore 284
Ashburn 147
Ho Chi Minh City 84
Council Bluffs 77
Hanoi 70
Beijing 69
Lauterbourg 64
New York 52
Helsinki 45
Hong Kong 42
Bordighera 39
Los Angeles 30
Milan 28
Santa Clara 28
Phoenix 27
Rome 26
Frankfurt am Main 24
Buffalo 21
Chicago 16
Dallas 15
São Paulo 14
Houston 12
Tokyo 12
Toronto 12
Boardman 11
Atlanta 9
Haiphong 9
Mexico City 9
Da Nang 8
Las Vegas 8
Naples 8
Tianjin 8
Bari 7
Biên Hòa 7
Brasília 7
City of London 7
Kingston 7
Kyiv 7
Miami 7
Newark 7
Rio de Janeiro 7
Florence 6
Johannesburg 6
London 6
Paris 6
Zurich 6
Hải Dương 5
Lahore 5
Piscataway 5
Queens 5
San Francisco 5
Turin 5
Washington 5
Amsterdam 4
Bangkok 4
Birmingham 4
Boston 4
Brooklyn 4
Bắc Giang 4
Charlotte 4
Denver 4
Fort Wayne 4
Kansas City 4
Louisville 4
Madrid 4
Montreal 4
Orem 4
Peoria 4
San José 4
Stockholm 4
The Bronx 4
Baghdad 3
Bắc Ninh 3
Cairo 3
Caracas 3
Curitiba 3
Dhaka 3
Figino 3
Jakarta 3
Lamezia Terme 3
Manchester 3
Mississauga 3
Mosul 3
Motta di Livenza 3
New Orleans 3
Nha Trang 3
North Bergen 3
Nuremberg 3
Orlando 3
Quito 3
San Antonio 3
San Juan 3
San Salvador 3
Santiago 3
Shanghai 3
Totale 10.983
Salva come PNG Salva come JPEG
Nome #
Clinical characteristics, management and in-hospital mortality of patients with COVID-19 In Genoa, Italy 355
The Ligurian Human Immunodeficiency Virus Clinical Network: A Web Tool to Manage Patients With Human Immunodeficiency Virus in Primary Care and Multicenter Clinical Trials 251
Effectiveness, safety, durability and immune recovery in a retrospective, multicentre, observational cohort of ART-experienced, HIV-1-infected patients receiving maraviroc 248
Budget impact analysis of sofosbuvir-based regimens for the treatment of HIV/HCV-coinfected patients in northern Italy: A multicenter regional simulation 233
A Standard Interface for Data Reuse in Infectious Diseases 231
A Web based tool for antimicrobial resistance evaluation in immunocompromised patient 219
Budget Impact Analysis of Sofosbuvir-Based Regimens for The Treatment of Hiv/Hcv Co-Infected Patients In Northern Italy: The Liguria Region Simulation 212
Candida auris Candidemia in Critically Ill, Colonized Patients: Cumulative Incidence and Risk Factors 211
A comparison of inpatient admissions in 2012 from two European countries 205
Use of colistin in adult patients: a cross-sectional study 205
External validation of unsupervised COVID-19 clinical phenotypes and their prognostic impact 204
Use of maraviroc in clinical practice: a multicenter observational study 200
Bronchoalveolar lavage fluid characteristics and outcomes of invasively mechanically ventilated patients with COVID-19 pneumonia in Genoa, Italy 199
Cost per care of the first year of direct antiviral agents in the liguria region: A multicenter analysis 198
Ricoveri ospedalieri dei pazienti con infezione da HIV in Liguria: risultati preliminari dello studio ACTEA 197
Prevalence and prognostic value of cardiac troponin in elderly patients hospitalized for COVID-19 197
Multicentre Clinical Trials’ data management: A hybrid solution to exploit the strengths of Electronic Data Capture and Electronic Health Records systems 194
Rete Ligure dell’HIV: due anni di esperienza nella gestione del dato clinico 191
Inpatient admissions of patients living with HIV in two European centres (UK and Italy); comparisons and contrasts 189
Prevalence and Clinical Significance of Persistent Viral Shedding in Hospitalized Adult Patients with SARS-CoV-2 Infection: A Prospective Observational Study 186
Bloodstream infections in critically ill patients with COVID-19 184
Control of the HIV-1 DNA reservoir is associated in vivo and in vitro with NKp46/NKp30 (CD335 CD337) inducibility and interferon gamma production by transcriptionally unique NK cells 181
Relationship between innate immunity, soluble markers and metabolic-clinical parameters in HIV+ patients ART treated with HIV-RNA < 50 cp/mL 178
On-field evaluation of a ultra-rapid fluorescence immunoassay as a frontline test for SARS-CoV-2 diagnostic 171
Weight gain: A possible side effect of all antiretrovirals 167
Improvement of lipid profile after switching from efavirenz or ritonavir-boosted protease inhibitors to rilpivirine or once-daily integrase inhibitors: Results from a large observational cohort study (SCOLTA) 162
Assessment of appropriateness of first-line combined antiretroviral treatment (cART): the preliminary results of Liguria experience V.E.L.A. study 159
From Liguria HIV Web to Liguria Infectious Diseases Network: How a Digital Platform Improved Doctors' Work and Patients' Care 155
Web interaction to improve collaboration in monitoring of microbial infections 154
Tocilizumab and steroid treatment in patients with COVID-19 pneumonia 154
Extensive activation, tissue trafficking, turnover and functional impairment of NK cells in COVID-19 patients at disease onset associates with subsequent disease severity 151
LiHlm-Web: a web-application in order to collect, share and analyze immunological data of HIV patients in multicentric studies 149
CD8+CD28-CD127loCD39+Treg Expansion: a New Pathogenic Mechanism for HIV Infection? 149
Reactivation of Herpes Simplex Virus Type 1 (HSV-1) Detected on Bronchoalveolar Lavage Fluid (BALF) Samples in Critically Ill COVID-19 Patients Undergoing Invasive Mechanical Ventilation: Preliminary Results from Two Italian Centers 149
Aspergillus-PCR in bronchoalveolar lavage - diagnostic accuracy for invasive pulmonary aspergillosis in critically ill patients 147
CD8+CD28-CD127loCD39+ T reg: a new biomarker for HIV infection 147
Successful antiretroviral therapy by using unusual antiretroviral combinations in heavily pre-treated patients: two case reports 146
The impact of liver disease: a leading cause of hospital admissions in people living vith HIV 143
Genetic polymorphisms of IL28b gene as predictors of response to dual therapy in genotypes 1 and 4-HCV and HIV/HCV-infected patients 140
Distinct features of immune activation and exhaustion markers in people with perinatally-acquired HIV 136
Successful antiretroviral therapy by using unusual antiretroviral combinations in heavily pre-treated patients: two case reports 136
Early effects of ventilatory rescue therapies on systemic and cerebral oxygenation in mechanically ventilated COVID-19 patients with acute respiratory distress syndrome: a prospective observational study 135
Prevalence of acquired resistance mutations in a large cohort of perinatally infected HIV-1 patients 134
A very rare case of mycobacterium gordonae infection of the breast 133
Incidence and Prognosis of Ventilator-Associated Pneumonia in Critically Ill Patients with COVID-19: A Multicenter Study 133
Short Course of Antifungal Therapy in Patients With Uncomplicated Candida Bloodstream Infection: Another Case of Less Is More in the Clinical Setting? 132
Valutazione di parametri di immunità innata e di infiammazione correlati ad aspetti clinico-metabolici in una coorte di pazienti HIV positivi con carica virale non rilevabile 132
Enterococcal bloodstream infections in critically ill patients with COVID-19: a case series 130
A comparative analysis of the first and second COVID-19 wave in Italy: evaluation of mortality in the Infectious Disease Unit of Genoa University Hospital 128
Lung distribution of gas and blood volume in critically ill COVID-19 patients: a quantitative dual-energy computed tomography study 127
Characterization of T lymphocytes in severe COVID-19 patients 127
High-temporal resolution profiling reveals distinct immune trajectories following the first and second doses of COVID-19 mRNA vaccines 123
Raltegravir-based therapy in a cohort of HIV/HCV co-infected individuals 122
Lower blood levels of isavuconazole in critically ill patients compared with other populations: possible need for therapeutic drug monitoring 122
Muscle symptoms and creatine phosphokinase elevations in patients receiving raltegravir in clinical practice: Results from the SCOLTA project long-term surveillance 119
Use of ceftaroline in hospitalized patients with and without covid-19: A descriptive cross-sectional study 119
The Ligurian HIV network: How medical informatics standards can help clinical research 118
Utilizzo di Maraviroc nella pratica clinica: studio multicentrico osservazionale (MARHIV STUDY) 117
Early administration of bamlanivimab in combination with etesevimab increases the benefits of covid-19 treatment: Real-world experience from the liguria region 117
Effect of SARS-CoV-2 vaccination in a vulnerable COVID-19 cohort: a real-life experience in an Italian Hospital 115
HCMV-controlling NKG2C+ NK cells originate from novel circulating inflammatory precursors 113
T2Bacteria and T2Resistance Assays in Critically Ill Patients with Sepsis or Septic Shock: A Descriptive Experience 112
Durability, safety, and efficacy of rilpivirine in clinical practice: results from the SCOLTA project 110
Spread of carbapenem-resistant gram-negatives and candida auris during the covid-19 pandemic in critically ill patients: One step back in antimicrobial stewardship? 110
Outcome of early treatment of SARS-CoV-2 infection in patients with haematological disorders 109
Immunological profile of an infant treated with integrase inhibitor from the neonatal period 106
The Longest Persistence of Viable SARS-CoV-2 With Recurrence of Viremia and Relapsing Symptomatic COVID-19 in an Immunocompromised Patient-A Case Study 104
Una rete multicentrica standardizzata per gestire e analizzare le co-morbidità e gli effetti collaterali legati a terapie HAART in pazienti con infezione da HIV 103
Inflammatory effects of atazanavir/ritonavir versus darunavir/ritonavir in treatment naïve, HIV-1-infected patients 103
Neutralizing monoclonal antibodies for the prevention of severe COVID-19: a retrospective study during Omicron BA.1 variant surge 102
Healthcare Worker Study Cohort to Determine the Level and Durability of Cellular and Humoral Immune Responses after Two Doses of SARS-CoV-2 Vaccination 102
Higher mortality and intensive care unit admissions in COVID-19 patients with liver enzyme elevations 102
Triple combination therapy with two antivirals and monoclonal antibodies for persistent or relapsed SARS-CoV-2 infection in immunocompromised patients 101
1942. Effect of {SARS}-{CoV}-2 Vaccination in a Frailty {COVID}-19 Cohort: a Real Life Experience in a Northern Italy Hospital 101
Lipid profile improvement in virologically suppressed hiv-1-infected patients switched to dolutegravir/ abacavir/lamivudine: Data from the SCOLTA project 101
Clinical efficacy of eucaloric ketogenic nutrition in the COVID-19 cytokine storm: A retrospective analysis of mortality and intensive care unit admission 101
Case report: Sotrovimab, remdesivir and nirmatrelvir/ritonavir combination as salvage treatment option in two immunocompromised patients hospitalized for COVID-19 99
High doses of hydroxychloroquine do not affect viral clearance in patients with SARS-CoV-2 infection 99
Early Clinical Experience with Molnupiravir for Mild to Moderate Breakthrough COVID-19 among Fully Vaccinated Patients at Risk for Disease Progression 98
Behind the screens: Clinical decision support methodologies - A review 98
Ten Years of Medical Informatics and Standards Support for Clinical Research in an Infectious Diseases Network 96
Clinical presentation of secondary infectious complications in COVID-19 patients in intensive care unit treated with tocilizumab or standard of care 91
Levels of beta-D-glucan in Candida auris supernatants, an in vitro and in vivo preliminary study 91
Durability of Dolutegravir-Based Regimens: A 5-Year Prospective Observational Study 91
Clinical significance of inflammatory markers of bacterial infection in critically ill patients with COVID-19 after treatment with anti-inflammatory and immunomodulatory drugs: A complex new scenario 89
Prevalence of Viral Hepatitis in Unselected, Consecutively Enrolled Patients Hospitalised for SARS-CoV-2 87
High prevalence of olfactory and taste disorder during SARS-CoV-2 infection in outpatients 79
West Nile virus: epidemiology, prevention, clinical features, diagnosis, treatment, and open research questions 76
Factors Associated With Weight Gain in People Treated With Dolutegravir 72
Clinical characteristics and outcomes of vaccinated patients hospitalised with SARS-CoV-2 breakthrough infection: Multi-IPV, a multicentre study in Northern Italy 66
Is a step-down antiretroviral therapy necessary to fight severe acute respiratory syndrome coronavirus 2 in HIV-infected patients? 66
Early and Polyantigenic CD4 T Cell Responses Correlate with Mild Disease in Acute COVID-19 Donors 54
Triple antiviral treatment for COVID-19 in an immunocompromised patient 21
Totale 13.019
Salva come PNG Salva come JPEG
Categoria #
all - tutte 48.932
article - articoli 42.954
book - libri 0
conference - conferenze 5.586
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 392
Totale 97.864
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022723 0 0 38 73 47 46 33 180 70 87 42 107
2022/20231.299 96 134 11 156 147 163 54 86 140 102 187 23
2023/2024832 43 82 16 106 80 171 50 53 34 33 62 102
2024/20252.491 80 146 60 189 251 227 287 501 90 125 286 249
2025/20264.485 555 171 482 317 531 222 570 222 344 428 298 345
2026/2027678 326 136 216 0 0 0 0 0 0 0 0 0
Totale 13.019